Olson KL - Search Results

1

Factors related to adherence to statin therapy.

McGinnis B, Olson KL, Magid D, Bayliss E, Korner EJ, Brand DW, Steiner JF. McGinnis B, et al. Among authors: olson kl. Ann Pharmacother. 2007 Nov;41(11):1805-11. doi: 10.1345/aph.1K209. Epub 2007 Oct 9. Ann Pharmacother. 2007. PMID: 17925498

2

Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organization.

Olson KL, Rasmussen J, Sandhoff BG, Merenich JA; Clinical Pharmacy Cardiac Risk Service Study Group. Olson KL, et al. Arch Intern Med. 2005 Jan 10;165(1):49-54. doi: 10.1001/archinte.165.1.49. Arch Intern Med. 2005. PMID: 15642874

3

Evaluation of cases of severe statin-related transaminitis within a large health maintenance organization.

Charles EC, Olson KL, Sandhoff BG, McClure DL, Merenich JA. Charles EC, et al. Among authors: olson kl. Am J Med. 2005 Jun;118(6):618-24. doi: 10.1016/j.amjmed.2005.02.008. Am J Med. 2005. PMID: 15922693

4

Complementary and alternative therapies for the management of dyslipidemia.

Nies LK, Cymbala AA, Kasten SL, Lamprecht DG, Olson KL. Nies LK, et al. Among authors: olson kl. Ann Pharmacother. 2006 Nov;40(11):1984-92. doi: 10.1345/aph.1H040. Epub 2006 Oct 17. Ann Pharmacother. 2006. PMID: 17047144 Review.

5

Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease.

Merenich JA, Olson KL, Delate T, Rasmussen J, Helling DK, Ward DG; Clinical Pharmacy Cardiac Risk Service Study Group. Merenich JA, et al. Among authors: olson kl. Pharmacotherapy. 2007 Oct;27(10):1370-8. doi: 10.1592/phco.27.10.1370. Pharmacotherapy. 2007. PMID: 17896892

6

Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease.

Ho PM, Magid DJ, Shetterly SM, Olson KL, Peterson PN, Masoudi FA, Rumsfeld JS. Ho PM, et al. Among authors: olson kl. Arch Intern Med. 2008 Feb 11;168(3):271-6. doi: 10.1001/archinternmed.2007.72. Arch Intern Med. 2008. PMID: 18268167

7

Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease.

Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, Masoudi FA, Rumsfeld JS. Ho PM, et al. Among authors: olson kl. Am Heart J. 2008 Apr;155(4):772-9. doi: 10.1016/j.ahj.2007.12.011. Am Heart J. 2008. PMID: 18371492

8

Factors associated with recurrent coronary events among patients with cardiovascular disease.

McConnell KJ, Olson KL, Delate T, Merenich JA; Clinical Pharmacy Cardiac Risk Service Study Group. McConnell KJ, et al. Among authors: olson kl. Pharmacotherapy. 2009 Aug;29(8):906-13. doi: 10.1592/phco.29.8.906. Pharmacotherapy. 2009. PMID: 19637943

9

Statin adherence and mortality in patients enrolled in a secondary prevention program.

McGinnis BD, Olson KL, Delate TM, Stolcpart RS. McGinnis BD, et al. Among authors: olson kl. Am J Manag Care. 2009 Oct;15(10):689-95. Am J Manag Care. 2009. PMID: 19845421 Free article.

10

Reduced health care expenditures after enrollment in a collaborative cardiac care service.

Delate T, Olson KL, Rasmussen J, Hutka K, Sandhoff B, Hornak R, Merenich J; Clinical Pharmacy Cardiac Risk Service Study Group. Delate T, et al. Among authors: olson kl. Pharmacotherapy. 2010 Nov;30(11):1127-35. doi: 10.1592/phco.30.11.1127. Pharmacotherapy. 2010. PMID: 20973686

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters